Inventor · disambiguated record
F. Anthony Romero
Also filed as: ROMERO F ANTHONY
39 granted patents·26 pending applications·84 citations·filing 2009–2025
96Inventor score
Top patents by PatentIndex Score
65 records- 0196US12378239B2Compounds as GLP-1R agonistsTERNS PHARMACEUTICALS INC·Filed 2025·Granted Aug 5, 2025·1 cites·20 claims
- 0296US12378237B2Compounds as GLP-1R agonistsTERNS PHARMACEUTICALS INC·Filed 2025·Granted Aug 5, 2025·1 cites·20 claims
- 0396US12378236B2Compounds as GLP-1R agonistsTERNS PHARMACEUTICALS INC·Filed 2025·Granted Aug 5, 2025·1 cites·20 claims
- 0496US12378238B2Compounds as GLP-1R agonistsTERNS PHARMACEUTICALS INC·Filed 2025·Granted Aug 5, 2025·1 cites·20 claims
- 0596US12024507B2Compounds as GLP-1R agonistsTERNS PHARMACEUTICALS INC·Filed 2022·Granted Jul 2, 2024·14 cites·32 claims
- 0692US12240835B2Substituted benzamides as intermediates in the synthesis of inhibitors of tyrosine kinase enzymatic activityTERNS PHARMACEUTICALS INC·Filed 2023·Granted Mar 4, 2025·1 cites·4 claims
- 0792US9763922B2Therapeutic compounds and uses thereofGENENTECH INC·Filed 2015·Granted Sep 19, 2017·9 cites·20 claims
- 0891US11858915B2Polo like kinase 4 inhibitorsORIC PHARMACEUTICALS INC·Filed 2023·Granted Jan 2, 2024·3 cites·21 claims
- 0991US11203587B2Thyroid hormone receptor beta agonist compoundsTERNS INC·Filed 2019·Granted Dec 21, 2021·6 cites·21 claims
- 1091US10800767B2Thyroid hormone receptor beta agonist compoundsTERNS INC·Filed 2019·Granted Oct 13, 2020·11 cites·21 claims
- 1190US10889571B2Substituted benzoimidazoles and imidazo[4,5-c]pyridines for treating certain leukemiasTERNS INC·Filed 2019·Granted Jan 12, 2021·4 cites·34 claims
- 1289US10519197B1Peptide-based proteasome inhibitors for treating conditions mediated by senescent cells and for treating cancerUNITY BIOTECHNOLOGY INC·Filed 2019·Granted Dec 31, 2019·3 cites·14 claims
- 1387US10308614B2Therapeutic compounds and uses thereofGENENTECH INC·Filed 2017·Granted Jun 4, 2019·4 cites·21 claims
- 1486US10307426B2Therapeutic compounds and compositions, and methods of use thereofGENENTECH INC·Filed 2018·Granted Jun 4, 2019·4 cites·29 claims
- 1586US2025282772A1Compounds as glp-1r agonistsTERNS PHARMACEUTICALS INC·Filed 2024·Application pending·0 cites
- 1683US11247989B2Therapeutic compounds and uses thereofGENENTECH INC·Filed 2018·Granted Feb 15, 2022·2 cites·8 claims
- 1783US10206931B2Therapeutic compounds and uses thereofGENENTECH INC·Filed 2017·Granted Feb 19, 2019·5 cites·17 claims
- 1880US2023150998A1Compounds as glp-1r agonistsTERNS PHARMACEUTICALS INC·Filed 2022·Application pending·0 cites
- 1979US10183009B2Therapeutic compounds and uses thereofGENENTECH INC·Filed 2017·Granted Jan 22, 2019·3 cites·22 claims
- 2078US12454524B2(r)-n-(4-(chlorodifluoromethoxy)phenyl)-2-(difluoromethyl)-1-(1-hydroxypropan-2-yl)-7-(pyrimidin-5-yl)-1H-benzo[d]imidazole-5-carboxamide, or a pharmaceutically acceptable salt or tautomer thereof, for treating certain leukemiasTERNS PHARMACEUTICALS INC·Filed 2025·Granted Oct 28, 2025·0 cites·30 claims
- 2177US12486261B2Compounds as GLP-1R agonistsTERNS PHARMACEUTICALS INC·Filed 2024·Granted Dec 2, 2025·0 cites·46 claims
- 2276US10696655B2Therapeutic compounds and uses thereofGENENTECH INC·Filed 2018·Granted Jun 30, 2020·1 cites·20 claims
- 2375US2023242530A18-(azetidin-1-yl)-[1,2,4]triazolo[1,5-a]pyridinyl compounds, compositions and methods of use thereofGENENTECH INC·Filed 2023·Application pending·0 cites
- 2474US11155557B2Pyrazolopyrimidine compounds and methods of use thereofGENENTECH INC·Filed 2019·Granted Oct 26, 2021·1 cites·19 claims
- 2574US2025276961A1Compounds for treating certain leukemiasTERNS PHARMACEUTICALS INC·Filed 2025·Application pending·0 cites
- 2672US2025236615A1Thyroid hormone receptor beta agonist compoundsTERNS INC·Filed 2024·Application pending·0 cites
- 2771US8394969B2Cyclic benzimidazole derivatives useful as anti-diabetic agentsBOOKSER BRETT C·Filed 2009·Granted Mar 12, 2013·4 cites·19 claims
- 2870US12312339B2Polo like kinase 4 inhibitorsORIC PHARMACEUTICALS INC·Filed 2023·Granted May 27, 2025·0 cites·22 claims
- 2970US11649241B2Pyrazolochlorophenyl compounds, compositions and methods of use thereofGENENTECH INC·Filed 2021·Granted May 16, 2023·0 cites·4 claims
- 3070US2022024945A1Therapeutic compounds and compositions, and methods of use thereofGENENTECH INC·Filed 2021·Application pending·0 cites
- 3169US8742110B2Spiroxazolidinone compoundsDUFFY JOSEPH L·Filed 2011·Granted Jun 3, 2014·3 cites·15 claims
- 3268US12247032B2Substituted pyrazolo[1,5-a]pyrimidines as inhibitors of JAK kinasesGENENTECH INC·Filed 2022·Granted Mar 11, 2025·0 cites·1 claims
- 3368US2019240227A1Therapeutic compounds and compositions, and methods of use thereofGENENTECH INC·Filed 2019·Application pending·0 cites
- 3467US2022348561A1Thyroid hormone receptor beta agonist compoundsTERNS PHARMACEUTICALS INC·Filed 2022·Application pending·0 cites
- 3566US8329914B2Cyclic benzimidazole derivatives useful as anti-diabetic agentsBAO JIANMING·Filed 2009·Granted Dec 11, 2012·1 cites·17 claims
- 3665US2020352951A1Therapeutic compounds and compositions, and methods of use thereofGENENTECH INC·Filed 2020·Application pending·0 cites
- 3765US2024270722A1Polo like kinase 4 inhibitorsORIC PHARMACEUTICALS INC·Filed 2022·Application pending·0 cites
- 3864US11731943B2Therapeutic compounds, compositions and methods of use thereofGENENTECH INC·Filed 2021·Granted Aug 22, 2023·0 cites·8 claims
- 3964US10689416B2Peptide-based proteasome inhibitors for treating conditions mediated by senescent cells and for treating cancerUNITY BIOTECHNOLOGY INC·Filed 2019·Granted Jun 23, 2020·0 cites·10 claims
- 4064US8563746B2Cyclic benzimidazole derivatives useful as anti-diabetic agentsDANG QUN·Filed 2009·Granted Oct 22, 2013·1 cites·13 claims
- 4164US2022127265A1Therapeutic compounds and uses thereofGENENTECH INC·Filed 2022·Application pending·0 cites
- 4263US2022089578A1Compounds as glp-1r agonistsTERNS PHARMACEUTICALS INC·Filed 2021·Application pending·0 cites
- 4363US2023322744A1Compounds as glp-1r agonistsTERNS PHARMACEUTICALS INC·Filed 2021·Application pending·0 cites
- 4462US2019202822A18-(azetidin-1-yl)-[1,2,4]triazolo[1,5-a]pyridinyl compounds, compositions and methods of use thereofGENENTECH INC·Filed 2019·Application pending·0 cites
- 4561US11168070B2Therapeutic compounds and uses thereofGENENTECH INC·Filed 2020·Granted Nov 9, 2021·0 cites·14 claims
- 4661US2020270248A18-(azetidin-1-yl)-[1,2,4]triazolo[1,5-a]pyridinyl compounds, compositions and methods of use thereofGENENTECH INC·Filed 2020·Application pending·0 cites
- 4759US2020062779A1Therapeutic compounds and compositions, and methods of use thereofGENENTECH INC·Filed 2019·Application pending·0 cites
- 4858US2025034159A1Inhibitors of epidermal growth factor receptorORIC PHARMACEUTICALS INC·Filed 2022·Application pending·0 cites
- 4957US2020399274A1Tetrazole-substituted pyrazolopyrimidine inhibitors of jak kinases and uses thereofGENENTECH INC·Filed 2020·Application pending·0 cites
- 5056US2024116912A1Compounds and methods for modulating fxrTERNS PHARMACEUTICALS INC·Filed 2021·Application pending·0 cites
Showing the top 50 of 65 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when F. Anthony Romero files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →